enEnglisch
Partners
All centers of the Network Southwest are members of the Society for Pediatric
Oncology and Hematology (GPOH). Here you can find information about the centers of our network and our cooperating partners.
Gesellschaft für pädiatrische Onkologie und Hämatologie (GPOH)
As a professional association, GPOH fulfills a variety of tasks in relation to patient treatment, research, education and training and cooperation with other professional associations
Deutsche Krebshilfe (German Cancer Aid)
The German Cancer Aid (Deutsche Krebshilfe) is Germany’s leading
non-governmental funding and non-profit-making organization of oncology-related
activities. Based in Bonn, our core objectives are to improve care for cancer
patients, promote research and to heighten cancer awareness through
information, education and public campaigns.
Kinderkrebsinfo.de
The information portal on oncologic and hematologic malignancies in children and adolescents provides information for affected children and their families as well as for experts. The website reflects the current knowledge in pediatric oncology.
Innovative Therapies for Children with Cancer in Europe
The Innovative Therapies for Children with Cancer (ITCC) Consortium was
created in 2003. It is a non profit organization. ITCC gathers 56 European paediatric
oncology departments with expertise in conducting early phase trials in
children and adolescents, and 25 European research laboratories. ITCC aims to
develop novel therapies for the treatment of paediatric and adolescent cancers
in cooperation with regulatory bodies, pharmaceutical enterprises, parents and
patients.
European Society of Paediatric Oncology
SIOPE is a pan-Europeam Organisation representing all professionals working in the field of childhood cancers. The Organisation aims to:
- support and facilitate education and training for health professionals
- bring together family groups, professionals and policy makers and optimise availability of information on childhood cancers
- promote international collaborative clinical trials